Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Brain Reward System in Apathy Associated With Alzheimer's Disease
NCT00254033Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextroamphetamine, methylphenidate in Alzheimer's disease (AD), sponsored by Sunnybrook Health Sciences Centre. Started Oct 2003; status: completed.
02
Drugs
dextroamphetaminemethylphenidate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00254033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254033.